IN8bio pauses glioblastoma program, halves workforce as it prioritizes leukemia asset
IN8bio is putting its brain tumor development program on the back burner and axing almost half of its employees in an effort to cut costs …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
